Serum hepcidin: reference ranges and biochemical correlates in the general population.

To date, concentrations of the promising biomarker hepcidin have only been assessed in serum of relatively small series of healthy volunteers and patients. We assessed age- and sex-stratified reference ranges of serum hepcidin concentration in a selected reference set and performed regression analyses to study associations between hepcidin and (biochemical) variables in a large, well-phenotyped sample of the general population (n = 2998). All participants filled out a questionnaire on lifestyle, health status, and medical history. Serum measurements of iron parameters, liver enzyme alanine aminotransferase, creatinine and C-reactive protein were available. Serum hepcidin concentrations were lower for premenopausal than for postmenopausal women (median, 4.1 nM vs 8.5 nM, respectively). Hepcidin concentrations in men were constant over age (median, 7.8 nM). Serum hepcidin was strongly associated with serum ferritin in men and women: β-coefficient of log-transformed variables (95% confidence interval): 0.78 (0.74-0.82) and 0.83 (0.78-0.88), respectively. Additional significant, though less strong, associations were observed for C-reactive protein and total iron binding capacity in men and for total iron binding capacity, alanine aminotransferase, and glomerular filtration rate in women. Our study provides age- and sex-specific reference ranges of serum hepcidin concentration and indicates ferritin as the primary correlate of serum hepcidin concentration.

[1]  N. Andrews,et al.  Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. , 2011, Blood.

[2]  K. Punnonen,et al.  Maternal serum hepcidin is low at term and independent of cord blood iron status , 2010, European journal of haematology.

[3]  D. Swinkels,et al.  Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. , 2010, Clinical chemistry.

[4]  M. Wessling-Resnick,et al.  Iron homeostasis and the inflammatory response. , 2010, Annual review of nutrition.

[5]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[6]  S. Bandinelli,et al.  Proinflammatory state, hepcidin, and anemia in older persons. , 2010, Blood.

[7]  E. Nemeth Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias , 2009, Advances in hematology.

[8]  S. Rajagopalan,et al.  Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate , 2010 .

[9]  D. Swinkels,et al.  Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[10]  M. Jadoul,et al.  Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. , 2009, Kidney international.

[11]  D. Swinkels,et al.  High‐sensitive radioimmunoassay for human serum hepcidin , 2009, British Journal of Haematology.

[12]  D. Swinkels,et al.  (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. , 2009, Analytical biochemistry.

[13]  T. Ganz,et al.  Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. , 2009, Journal of hepatology.

[14]  C. Datz,et al.  Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. , 2009, Blood.

[15]  D. Girelli,et al.  Hepcidin modulation in human diseases: from research to clinic. , 2009, World journal of gastroenterology.

[16]  D. Gale,et al.  Development of a novel immunoassay for the iron regulatory peptide hepcidin , 2009, British journal of biomedical science.

[17]  D. Girelli,et al.  Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization , 2008, Haematologica.

[18]  D. Girelli,et al.  Immunoassay for human serum hepcidin. , 2008, Blood.

[19]  D. Swinkels,et al.  Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  D. Girelli,et al.  Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry , 2008, PloS one.

[21]  N. Andrews,et al.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.

[22]  J. Wetzels,et al.  Age- and gender-specific reference values of estimated glomerular filtration rate in a Caucasian population: Results of the Nijmegen Biomedical Study. , 2008, Kidney international.

[23]  D. Swinkels,et al.  Hepcidin: from discovery to differential diagnosis , 2008, Haematologica.

[24]  L. Kiemeney,et al.  Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. , 2007, Kidney international.

[25]  D. Swinkels,et al.  Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. , 2007, Clinical chemistry.

[26]  H. Bayele,et al.  Cis and trans regulation of hepcidin expression by upstream stimulatory factor. , 2006, Blood.

[27]  T. Ganz,et al.  Suppression of hepcidin during anemia requires erythropoietic activity. , 2006, Blood.

[28]  Y. Le Marchand-Brustel,et al.  Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. , 2006, Gastroenterology.

[29]  T. Ganz,et al.  Regulation of iron acquisition and iron distribution in mammals. , 2006, Biochimica et biophysica acta.

[30]  T. Ganz,et al.  Hepcidin and iron-loading anemias. , 2006, Haematologica.

[31]  D. Swinkels,et al.  Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. , 2006, Clinical chemistry.

[32]  L. Kiemeney,et al.  Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. , 2006, Clinical chemistry.

[33]  D. Swinkels,et al.  Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. , 2005, Blood.

[34]  L. Goodnough,et al.  Anemia of chronic disease. , 2005, The New England journal of medicine.

[35]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[36]  Matthias W. Hentze,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .

[37]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[38]  J. Koziol,et al.  Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. , 2001, Clinical chemistry.

[39]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[40]  J. Cook,et al.  Evaluation of the iron status of a population. , 1976, Blood.